Prot #SP902: A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400mg/day Monotherapy in Subjects with Partial-onset Seizures

Project: Research project

Project Details

StatusFinished
Effective start/end date1/9/125/1/13

Funding

  • Chiltern International, Inc. (Prot #SP902)
  • UCB Biosciences, Inc. (Prot #SP902)